U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838740) titled 'A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities' on Sept. 09. Brief Summa... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838961) titled 'Brain Stimulation to Improvement After Cerebellar Damage' on Sept. 18. Brief Summary: The... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pl... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled Phase 2 study to investigate the effi... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839299) titled 'Bonafide Sleep Supplement for Menopausal Women With Impaired Sleep' on Sept. 15. Brief Su... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solu... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib ... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'N-Acetylcysteine or Erdosteine for Exacerbations of Chronic Obstructive Pulmonary Disease (NEX CO... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pemb... Read More